CME/CE: Oral Anticoagulants and Brain Bleeds

Publication Date:
Wed, 07/01/2015
By: Alere Staff

SPONSORED BY

MedPage Today

 

ACTIVE DATE

June 16, 2015 – June 16, 2017

 

CREDIT

Physicians: 0.25 AMA PRA Category 1 Credit(s) ™

 

DESCRIPTION

Restarting oral anticoagulation (OAC) after warfarin-related intracranial hemorrhage (ICH) in non-valvular atrial fibrillation (AF) patients reduces the otherwise elevated risk of ischemic stroke and/or mortality. Stopping antithrombotic treatment following ICH or treating with antiplatelet therapy instead of an oral anticoagulant is riskier than resuming OAC treatment.

 

LINK

http://www.medpagetoday.com/Cardiology/Strokes/52160